Jiro Kondo

Efficacy of dulaglutide after switching from incretin-related drugs in patients with type 2 diabetes and inadequate glycemic control

E. Kusano, Hiroyuki Ito, S. Antoku, 2021, Diabetology International.

Different renoprotective effects of luseogliflozin depend on the renal function at the baseline in patients with type 2 diabetes: A retrospective study during 12 months before and after initiation

E. Kusano, Hiroyuki Ito, S. Antoku, 2021, PloS one.

Constipation Is a Frequent Problem Associated with Vascular Complications in Patients with Type 2 Diabetes: A Cross-sectional Study

E. Kusano, Hiroyuki Ito, S. Antoku, 2022, Internal medicine.